Back to All Events

BIO International Convention

Featured Speaker 2017 BIO International Convention, the global event for biotechnology

The Whole Picture: Consideration of Personalized Medicine in Value Assessment Frameworks

10:15 AM–11:15 AM Jun 22, 2017

Room 6D

Speaker (3)

Donna Cryer, JD
President & CEO, Global Liver Institute

Roger Longman
Chief Executive OfficerReal Endpoints

Mike Ryan, PharmD
Senior Vice President, US Value, Access and Policy, Bristol-Myers Squibb

Moderator (1)
Jennifer Snow
Director of Health PolicyXcenda


Value assessment frameworks are a relatively new concept designed to help stakeholders determine what treatments provide the most value in healthcare. They are sometimes influential in determining what therapies are chosen by patients and their doctors, and often used to determine if those therapies will be covered and reimbursed by payers. How these frameworks consider personalized medicine is not yet clear. Designed before 25% of all new drugs were personalized medicines, value frameworks might need to evolve to keep pace with scientific discovery and recognize the leading role of diagnostic testing in targeting therapeutic use. This session will examine how value assessment frameworks have been developed historically, examine the current critiques of their processes and methodologies and explore how they might have to change in the future to support personalized medicine.

Session ID: 22286